The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III randomized trial of maintenance pegylated liposomal doxorubicin (PLD) / carboplatin versus without in patients with advanced ovarian cancer: An Asian Gynecologic Oncology Group study.
 
Chyong-Huey Lai
Research Funding - TTY Biopharm (Inst)
 
Elizabeth Vallikad
Research Funding - TTY Biopharm (Inst)
 
Hao Lin
No Relationships to Disclose
 
Lan-Yan Yang
No Relationships to Disclose
 
Yu-Che Ou
No Relationships to Disclose
 
Hung-Hsueh Chou
No Relationships to Disclose
 
Cheng-Tao Lin
Research Funding - TTY Biopharm (Inst)
 
Huei-Jean Huang
Research Funding - TTY Biopharm (Inst)
 
Kung-Gen Huang
Research Funding - TTC Biopharm (Inst)
 
Jentai Qiu
No Relationships to Disclose
 
Yao-Ching Hung
No Relationships to Disclose
 
Tzu-I Wu
No Relationships to Disclose